DNA genomics and precision medicine concept representing polygenic risk scores for cardiovascular disease prevention
| | | |

The Oxford Physician Who Edited the First Human Genome Is Now Learning to Write New Ones

Adrian Woolfson oversaw the first clinical trial to edit a living person’s DNA at Sangamo Therapeutics. At Genyro, the San Diego biotech he cofounded with Brian Hie and Kaihang Wang,…